首页> 外文会议>International Symposium of Biomedical Engineering >Centella asiatica as a Potential Plaque Stabilizer: Future Preventive Therapy for Cardiovascular Disease
【24h】

Centella asiatica as a Potential Plaque Stabilizer: Future Preventive Therapy for Cardiovascular Disease

机译:Centella Asiatica作为潜在的斑块稳定剂:未来的心血管疾病预防治疗

获取原文

摘要

WHO states that cardiovascular disease (CVD) is the cause of 31% of deaths worldwide, reaching 17.7 million deaths per year. Causes of CVD, including smoking, unbalanced food intake, low physical activity, and excessive alcohol consumption. The common pathophysiology of CVD is the formation of atherosclerotic plaques. It begins with endothelial dysfunction that is closely related to diabetes mellitus (DM). Existing treatment focus on preventing the formation of atherosclerotic plaques by lowering blood cholesterol levels and blood viscosity. It prevents the formation of shear strength that can damage the endothelial layer. Centella asiatica (CA) is a well-known herb used as an oxidative-stress remedy. Literature review was conducted by searching two journal databases, PubMed and Ebscohost. The search was carried out using Boolean Operator as follows: cardiovascular AND therapy AND "Centella asiatica". Sources are not year-limited and include animal studies, randomized-controlled trial reports or related reviews. Based on the literature review, various studies are linking the protective effect of CA on CVD. Ramachandran et al. conducted an in vivo study by using mice with DM. Lipid profiles of DM mice were given asiatic acid shifted towards normalcy, which reduces the risk of atherosclerotic plaque formation. Cesarone et al. conducted Randomized Controlled Trial (RCT) studies by using the group given CA therapy for 12 months. The study showed an increase in Gray-Scale median (GSM) parameters and an improvement in the texture of atherosclerotic plaques, which showed the formation of a stable with low risk for thrombus. Luzzi et al. conducted RCT study on high-oxidative stress asymptomatic patients given Pycnogenol and CA extract. It showed an increase in the stability of atherosclerotic plaque as indicated by an increase in plaque density, a decrease in the number and size of plaques. These results indicate the potential of CA as a good preventive cardiovascular thera
机译:谁指出,心血管疾病(CVD)是全球死亡人数的31%,每年达到1770万人死亡。 CVD的原因,包括吸烟,不平衡的食物摄入,低体育活动和过度的酒精消费。 CVD的常见病理生理学是动脉粥样硬化斑块的形成。它从内皮功能障碍开始,与糖尿病(DM)密切相关。现有治疗专注于通过降低血液胆固醇水平和血液粘度来防止形成动脉粥样硬化斑块。它可以防止剪切强度的形成,可以损坏内皮层。 Centella Asiatica(CA)是一种众所周知的草药,用作氧化胁迫补救措施。通过搜索两个期刊数据库,PubMed和EBSCohost进行文献综述。搜索是使用布尔运营商进行的,如下所示:心血管和治疗和“Centella Asiatica”。来源不是一年有限的,包括动物研究,随机对照的试验报告或相关审查。基于文献综述,各种研究正在将CA对CVD上的保护作用联系起来。 Ramachandran等人。使用DM小鼠进行体内研究。给予DM小鼠的脂质曲线,给予亚氨基酸朝向正常,这降低了动脉粥样硬化斑块形成的风险。 Cesarone等人。通过使用给定的Ca疗法进行12个月,通过使用该组进行随机对照试验(RCT)研究。该研究表明,灰度中值(GSM)参数增加以及动脉粥样硬化斑块的纹理的改善,显示出形成稳定性血栓的稳定性。 Luzzi等。对高氧化胁迫无症状患者进行了RCT研究,术后霉菌和CA提取物。它表明,动脉粥样硬化斑块的稳定性增加,如斑块密度的增加所示,斑块数量和斑块的尺寸减少。这些结果表明CA作为良好预防性心血管Thera的潜力

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号